🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣 New #breastcancer video podcast 📣 📹 From Dr Rena Callahan & Dr Roberto Salgado ➡️ Exploring the latest insights in #moleculartesting and targeted therapy for HR+/HER2- metastatic breast cancer Listen on Spotify/Apple : cor2ed.com/precision-onco… Supported by an Independent

➡️ Did TROPION-Breast01 final OS results reach statistical significance? ➡️ What do the data show about how Dato-DXd compares with chemotherapy? Get the answers from Prof. François-Clément Bidard & Dr Barbara Pistilli in this ESMO Virtual Plenary 2025 update 👇

🧬Precision oncology in HR+/HER2- metastatic #breastcancer. Dr Callahan and Dr Salgado discuss: Essential #biomarkers (ESR1m, PIK3CA, gBRCA) and their clinical implications, Liquid vs tumour biopsy – when and how? Single gene vs broad panel testing…and much more! 📹 Watch the

What are the next therapeutic options for pts w/ pretreated HR+/HER2- (IHC 0) mBC who have developed endocrine resistance? Discover how ADCs may offer a solution in this case-based video with Dr Barbara Pistilli. 📺 See more: cor2ed.com/breast-cancer-… Supported by an

📺 New case-based video on ADCs for HR+/HER2-metastatic #BreastCancer Dr Barbara Pistilli talks about: - The MoA of antibody–drug conjugates (ADCs) - ADCs currently available for HR+/HER2- mBC - Strategies for managing AEs Find out more! 👇 cor2ed.com/breast-cancer-… Endorsed by

Endocrine-resistant HR+/HER2− mBC remains a significant unmet need ADCs = more effective/tolerable later-line alternative to conventional chemotherapy This ⬆️ is just one key clinical takeaway from a case-based video by medical expert Dr Pistilli Get the rest and watch the

📢#ASCO25 is nearly here, keep a look out for our conference update! In this video, GI CONNECT member Dr Lizzy Smyth introduces the medical experts who will be joining us at ASCO ➡️ Prof. Mark Socinski: #NSCLC ➡️ Dr AttardLab: #ProstateCancer ➡️ Dr Lizzy Smyth :

📢#BreastCancer update from #ASCO25! Dr Paolo Tarantino shares breast cancer highlights from ASCO and gives his take on data from · SERENA-6 · ASCENT-04/KEYNOTE-D19 · DESTINY-Breast09 How will these data impact clinical practice? 📺 Watch the video to find out! See more

Join Leading Experts & COR2ED for Rapid Video Insights on Groundbreaking Data out of #ASCO25 LINK: buff.ly/He9wEAY a series of brief videos featuring Prof. Gerhardt Attard presenting late-breaking prostate cancer trial results from the AMPLITUDE study, Prof.

Catch up on highlights from #ASCO25! Experts joined us at ASCO to share their insights on how the latest data could change clinical practice ➡️ Prof. Mark Socinski: #NSCLC (downloadable slides also available) ➡️ Dr AttardLab: #ProstateCancer ➡️ Dr Lizzy Smyth: #GastricCancer

Discover the latest insights in molecular testing and targeted therapy for HR+/HER2- metastatic breast cancer with Dr. Rena Callahan and Dr. Roberto Salgado

When and how can HCPs use liquid biopsy for #biomarker testing in HR+/HER2- metastatic #breastcancer? ➡️Which biomarkers do you test for? ➡️How do you use test results effectively? Prof. Frédérique Penault-Llorca & Dr Aditya Bardia share their expert insights into this topic

🔍 Molecular testing—especially for 𝐸𝑆𝑅1 & 𝑃𝐼3𝐾 biomarkers—is critical in guiding second‑line therapy for HR⁺/HER2⁻ metastatic breast cancer. But when should you use liquid or tissue biopsy to detect progression‑associated mutations? 🎧 Join experts Dr Rena Callahan &

🎉 COR2ED has over 12k subscribers on YouTube! 🎉 Do you follow us? ▶️youtube.com/@cor2edthehear… Join over 12k HCPs on our YouTube channel and stay up to date with #MedEd videos as they’re released 🎓 #MedicalEducation #Oncology #BCSM #BreastCancer

How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC? 👉 Prof. François-Clément Bidard & Dr Barbara Pistilli share expert insights on the latest TROPION-Breast01 update, presenting the final OS results at the #ESMO Virtual Plenary 2025 See more about

How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC? 👉 Prof. François-Clément Bidard & Dr Barbara Pistilli share expert insights on the latest TROPION-Breast01 update, presenting the final OS results at the ESMO Virtual Plenary 2025 📺 See more